Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sahm

Showing results (431-440 of 451) with videos related to

Pageof 46
Sort By:
Acta Neuropathologica|August 6, 2021
Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumorsPhilipp Sievers, Sophie C Henneken, Christina Blume, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2021
Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively ValidatedSybren L N Maas, Damian Stichel, Thomas Hielscher, et al.
Pediatric Blood & Cancer|March 17, 2026
The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and SwitzerlandStefan Rutkowski, Michael C Frühwald, Gudrun Fleischhack, et al.
Nature Communications|October 9, 2025
Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Nature Communications|July 31, 2025
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Nature|December 6, 2019
The molecular landscape of ETMR at diagnosis and relapseSander Lambo, Susanne N Gröbner, Tobias Rausch, et al.
Nature Genetics|February 9, 2026
A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classificationSybren L N Maas, Yiheng Tang, Eric Stutheit-Zhao, et al.
Nature Medicine|November 9, 2023
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesWilliam C Chen, Abrar Choudhury, Mark W Youngblood, et al.
Neuro-Oncology|June 28, 2023
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndromeAnna S Kolodziejczak, Lea Guerrini-Rousseau, Julien Masliah Planchon, et al.
Cancer Discovery|August 10, 2021
The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence TargetsCornelis M van Tilburg, Elke Pfaff, Kristian W Pajtler, et al.
Pageof 46

Showing results (431-440 of 451) with videos related to

Sort By:
Pageof 46
Acta Neuropathologica|August 6, 2021
Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumorsPhilipp Sievers, Sophie C Henneken, Christina Blume, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2021
Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively ValidatedSybren L N Maas, Damian Stichel, Thomas Hielscher, et al.
Pediatric Blood & Cancer|March 17, 2026
The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and SwitzerlandStefan Rutkowski, Michael C Frühwald, Gudrun Fleischhack, et al.
Nature Communications|October 9, 2025
Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Nature Communications|July 31, 2025
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Nature|December 6, 2019
The molecular landscape of ETMR at diagnosis and relapseSander Lambo, Susanne N Gröbner, Tobias Rausch, et al.
Nature Genetics|February 9, 2026
A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classificationSybren L N Maas, Yiheng Tang, Eric Stutheit-Zhao, et al.
Nature Medicine|November 9, 2023
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesWilliam C Chen, Abrar Choudhury, Mark W Youngblood, et al.
Neuro-Oncology|June 28, 2023
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndromeAnna S Kolodziejczak, Lea Guerrini-Rousseau, Julien Masliah Planchon, et al.
Cancer Discovery|August 10, 2021
The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence TargetsCornelis M van Tilburg, Elke Pfaff, Kristian W Pajtler, et al.
Pageof 46